MENU
KALV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
KalVista Pharmaceuticals (KALV) Ownership - Who owns KalVista Pharmaceuticals?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
55 Cambridge Parkway
Phone
+1 857 999-0075
Employees
118
Web
https://www.kalvista.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
410.17M
P/E Ratio
N/A
Total Cash
135.78M
Projected Growth
N/A
Total Debt
6.21M
Revenue
N/A
Risk (Beta)
-0.14
Dividend Yield
N/A
Total Cash/Share
2.75
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
KALV
Capitalization
410M
P/E Ratio
N/A
Risk (Beta)
-0.14
Dividend Yield
N/A
Total Cash
136M
Total Cash/Share
2.75
Total Debt
6.21M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
134M
P/B Ratio
3.06
Cash Flow
N/A
Earnings
-3.68
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
43K
Current Ratio
6.87
Current Revenue Per Employee
68285.71
Dividends Per Share - Security
N/A
EBITDA
-162.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-104.41
Shares Held By Institutions
650M
Shares Outstanding - Current
49.4M
Total Liabilities
26.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-2.597
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
55 Cambridge Parkway
Phone
+1 857 999-0075
Employees
118
Web
https://www.kalvista.com